Author

Daniel L. Murphy

Cancer Research UK Scotland Institute

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Björn KruspigiD· 1 shared Colin S. WoodiD· 1 shared David P. SumptoniD· 1 shared Douglas StrathdeeiD· 1 shared Emanuel Jeldes· 1 shared Holly LeslieiD· 1 shared Ian R. PowleyiD· 1 shared Jim C. NormaniD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Björn KruspigORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Increased mRNA translation delays lung adenocarcinoma initiation and exposes a therapeutic vulnerability to MEK inhibitors

Luis Pardo, Madeleine Moore, Ruhi S. Deshmukh, Ian R. Powley, Joseph A. Waldron, Björn Kruspig, Lynn McGarry, Colin S. Wood, Holly Leslie, Mark M. Hughes, Emanuel Jeldes, June Munro, Louise E. Mitchell, Leah Officer-Jones, Rachel L. Pennie, , Jim C. Norman

This study shows that increased mRNA translation delays lung adenocarcinoma initiation and creates a vulnerability to MEK inhibitors in KRAS-driven tumors.

bioRxiv · Mar 19, 2025 · PreprintCancer Biology